Citation Impact
Citing Papers
A Phase II Trial of Lutikizumab, an Anti–Interleukin‐1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis
2019
The Presumed Hyporesponsive Behavior of Rheumatoid Arthritis T Lymphocytes Can Be Attributed to Spontaneous Ex Vivo Apoptosis rather than Defects in T Cell Receptor Signaling
2009
Patient-reported outcomes from a randomised phase III study of baricitinib in patients with rheumatoid arthritis and an inadequate response to biological agents (RA-BEACON)
2016
Synovitis in osteoarthritis: current understanding with therapeutic implications
2017 Standout
Infections requiring hospitalization in the abatacept clinical development program: an epidemiological assessment
2010
Prognostic factors for progression of clinical osteoarthritis of the knee: a systematic review of observational studies
2015
Insights into the efficacy of golimumab plus methotrexate in patients with active rheumatoid arthritis who discontinued prior anti-tumour necrosis factor therapy: post-hoc analyses from the GO-AFTER study
2013
Osteoarthritis year in review 2019: epidemiology and therapy
2020 Standout
The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis
2010 Standout
The clinical efficacy and safety of certolizumab pegol in rheumatoid arthritis
2010
Paracetamol: New Vistas of an Old Drug
2006
It's Good to Feel Better But It's Better To Feel Good and Even Better to Feel Good as Soon as Possible for as Long as Possible. Response Criteria and the Importance of Change at OMERACT 10: Figure 1.
2011
Intra-articular corticosteroids and the risk of knee osteoarthritis progression: results from the Osteoarthritis Initiative
2019
Rheumatoid arthritis
2018 Standout
Rheumatoid arthritis
2009
Promising bone-related therapeutic targets for rheumatoid arthritis
2009
Rheumatoid arthritis
2016 Standout
Synovial changes detected by ultrasound in people with knee osteoarthritis – a meta-analysis of observational studies
2016
Osteoarthritis: A disease of the joint as an organ
2012 Standout
Macrophage proliferation distinguishes 2 subgroups of knee osteoarthritis patients
2019
Abatacept in the treatment of patients with psoriatic arthritis: Results of a six‐month, multicenter, randomized, double‐blind, placebo‐controlled, phase II trial
2010
Inflammatory ultrasound features show independent associations with progression of structural damage after over 2 years of follow-up in patients with hand osteoarthritis
2014
Cell-autonomous and -non-autonomous roles of CTLA-4 in immune regulation
2011 StandoutNobel
The role of synovitis in osteoarthritis pathogenesis
2012
Imaging of Synovitis in Osteoarthritis: Current Status and Outlook
2011
Osteoarthritis
2015 Standout
Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors
2009
Biologic and oral disease-modifying antirheumatic drug monotherapy in rheumatoid arthritis
2013
Forget personalised medicine and focus on abating disease activity
2012
Incorporating the Treat-to-Target Concept in Rheumatoid Arthritis
2012
Use of abatacept in rheumatoid arthritis
2012
Graphical Tools for Network Meta-Analysis in STATA
2013 Standout
IL-6 in Inflammation, Immunity, and Disease
2014 Standout
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials
2010
Safety and Efficacy of the Selective Costimulation Modulator Abatacept in Patients with Rheumatoid Arthritis Receiving Background Methotrexate: A 5-year Extended Phase IIB Study
2009
Malignancies in the rheumatoid arthritis abatacept clinical development programme: an epidemiological assessment
2008
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
Molecular mechanisms of T cell co-stimulation and co-inhibition
2013 Standout
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Rheumatoid arthritis
2010 Standout
A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview
2009
Efficacy of VX-509 (decernotinib) in combination with a disease-modifying antirheumatic drug in patients with rheumatoid arthritis: clinical and MRI findings
2016
Baricitinib in Patients with Refractory Rheumatoid Arthritis
2016
An update on the pathophysiology of osteoarthritis
2016 Standout
Abatacept for Rheumatoid Arthritis: A Cochrane Systematic Review
2010
Safety Profile of Baricitinib in Patients with Active Rheumatoid Arthritis with over 2 Years Median Time in Treatment
2018
OARSI Clinical Trials Recommendations: Hip imaging in clinical trials in osteoarthritis
2015
Ultrasound-detected inflammation predicts radiographic progression in hand osteoarthritis after 5 years
2015
Pharmacological Properties and Molecular Mechanisms of Thymol: Prospects for Its Therapeutic Potential and Pharmaceutical Development
2017 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Nrf2 activation improves experimental rheumatoid arthritis
2023 StandoutNobel
T‐cell receptor signaling and the pathogenesis of autoimmune arthritis: insights from mouse and man
2012 StandoutNobel
Clinically Important Changes in Short Form 36 Health Survey Scales for Use in Rheumatoid Arthritis Clinical Trials: The Impact of Low Responsiveness
2014
Diagnosis and Treatment of Hip and Knee Osteoarthritis
2021 Standout
Psoriasis Pathogenesis and Treatment
2019 Standout
Description of the Efficacy and Safety of Three New Biologics in the Treatment of Rheumatoid Arthritis
2010
The clinical utility of inhibiting CD28‐mediated costimulation
2009
Induction of autoimmune disease by deletion of CTLA-4 in mice in adulthood
2016 StandoutNobel
Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis
2020
Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations
2013
Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics
2017
Osteoarthritis: an update with relevance for clinical practice
2011 Standout
The role of synovitis in osteoarthritis
2010
Works of Manuela Le Bars being referenced
Achievement of sustained low disease activity state predicts the absence of structural damage progression in patients with Rheumatoid arthritis: insights from the abatacept database.
2009
Evaluation of different methods used to assess disease activity in rheumatoid arthritis: analyses of abatacept clinical trial data
2008
Clinical and ultrasonographic predictors of joint replacement for knee osteoarthritis: results from a large, 3-year, prospective EULAR study
2009
Longterm Safety and Efficacy of Abatacept Through 5 Years of Treatment in Patients with Rheumatoid Arthritis and an Inadequate Response to Tumor Necrosis Factor Inhibitor Therapy
2012
Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapy
2007
Impact of intravenous abatacept on synovitis, osteitis and structural damage in patients with rheumatoid arthritis and an inadequate response to methotrexate: the ASSET randomised controlled trial
2012
The 6-month safety and efficacy of abatacept in patients with rheumatoid arthritis who underwent a washout after anti-tumour necrosis factor therapy or were directly switched to abatacept: the ARRIVE trial
2008
Single and multiple dose pharmacokinetics of acetaminophen (paracetamol) in polymedicated very old patients with rheumatic pain.
2001